Studies show that, when given once every six months, the injections can cut the risk of developing Covid by nearly 80 per cent. Dr Michelle Willicombe, a kidney specialist at Imperial College Healthcare NHS Trust in London, says: ‘The NHS has no plan to offer extremely vulnerable patients Evusheld and it’s incredibly worrying. Something needs to change.’Charities claim the lack of action from NHS England on Evusheld is because Covid is no longer viewed as a priority. Patients are given Evusheld as two injections once every six months, and, based on trials carried out in 2021, it reduces the risk of developing symptomatic Covid by more than three quarters. A spokesman for the Department of Health and Social Care said: ‘The UK Health Security Agency is carrying out Government-funded testing on Evusheld’s effectiveness against the Omicron variant.

Source: Daily Mail April 24, 2022 05:36 UTC